SCHEMBL2869233

SCHEMBL2869233

[CH]1CCCCCNN1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2870637 1.00
SCHEMBL78894 0.97
SCHEMBL20424 0.88
SCHEMBL22706 0.74
SCHEMBL1089494 0.72
SCHEMBL1088460 0.72
SCHEMBL1088459 0.72
SCHEMBL779806 0.71
SCHEMBL194674 0.69
SCHEMBL5010068 0.69 ALDH1A1 (0.33)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 24 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4638000-A HYPOTENSIVES, ANGIOTENSIN INHIBITORS TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 1987-01-20 US claimed
US-4548932-A ANGIOTENSIN INHIBITOR, HYPOTENSIVE AGENT TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 1985-10-22 US claimed
EP-3408258-A1 ORGANIC REACTIONS CARRIED OUT IN AQUEOUS SOLUTION IN THE PRESENCE OF A HYDROXYALKYL(ALKYL)CELLULOSE OR AN ALKYLCELLULOSE Abbvie Deutschland GmbH & Co. KG (DE) 2018-12-05 EP disclosed
WO-2017157929-A1 QUINOLINE COMPOUNDS SUITABLE FOR TREATING DISORDERS THAT RESPOND TO THE MODULATION OF THE SEROTONIN 5-HT6 RECEPTOR AbbVie Deutschland GmbH & Co. KG (DE) 2017-09-21 WO disclosed
WO-2017129796-A1 ORGANIC REACTIONS CARRIED OUT IN AQUEOUS SOLUTION IN THE PRESENCE OF A HYDROXYALKYL(ALKYL)CELLULOSE OR AN ALKYLCELLULOSE AbbVie Deutschland GmbH & Co. KG (DE) 2017-08-03 WO disclosed
US-8592420-B2 Method of treating an anxiety disorder KYOWA HAKKO KIRIN CO., LTD. (JP) 2013-11-26 US disclosed
US-20120232089-A1 METHOD OF TREATING AN ANXIETY DISORDER KYOWA HAKKO KIRIN CO., LTD. (JP) 2012-09-13 US disclosed
US-8202869-B2 Method of treating an anxiety disorder KYOWA HAKKO KIRIN CO., LTD. (JP) 2012-06-19 US disclosed
US-7851478-B2 Agent for preventing and/or treating movement disorder KYOWA HAKKO KIRIN CO., LTD. (JP) 2010-12-14 US disclosed
EP-2258372-A1 A2A antagonists for use in the treatment of motor disorders Kyowa Hakko Kirin Co., Ltd. (JP) 2010-12-08 EP disclosed
US-20090105277-A1 AGENT FOR PREVENTING AND/OR TREATING MOVEMENT DISORDER KYOWA HAKKO KOGYO CO., LTD. (JP) 2009-04-23 US disclosed
EP-1736474-A1 PIPERIDINE DERIVATIVE KYOWA HAKKO KOGYO CO., LTD. (JP) 2006-12-27 EP disclosed
US-20060281770-A1 Method of treating an anxiety disorder KYOWA HAKKO KOGYO CO. LTD (JP) 2006-12-14 US disclosed
EP-1631294-A1 A METHOD OF TREATING AN ANXIETY DISORDER KYOWA HAKKO KOGYO CO., LTD. (JP) 2006-03-08 EP disclosed
WO-2004108137-A1 A METHOD OF TREATING AN ANXIETY DISORDER KYOWA HAKKO KOGYO CO., LTD. (JP) 2004-12-16 WO disclosed
US-4739066-A HYPOTENSIVE AGENTS, ANGIOTENSIN INHIBITORS TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 1988-04-19 US disclosed
US-4638000-A HYPOTENSIVES, ANGIOTENSIN INHIBITORS TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 1987-01-20 US disclosed
US-4591458-A ENZYME INHIBITORS; HYPOTENSIVE AGENTS TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 1986-05-27 US disclosed
US-4548932-A ANGIOTENSIN INHIBITOR, HYPOTENSIVE AGENT TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 1985-10-22 US disclosed
EP-0135349-A1 Condensed seven-membered ring compounds and their production and use Takeda Chemical Industries, Ltd. (JP) 1985-03-27 EP disclosed